Policy analysis, advocacy, legislation and litigation: 238 votes for 57 nominations. Top 10 received 47.9% of votes
| Paper | Votes | Citations |
|---|---|---|
| Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA1998;:–70. | 14 | 102 |
| Chapman S. Advocacy for public health: a primer. J Epidemiol Community Health2004;:–5. | 13 | 0 |
| Henningfield JE, Benowitz NL, Connolly GN et al. Reducing tobacco addiction through tobacco product regulation. Tobacco Control 2004;13:132–5. | 12 | 4 |
| Barnes DE, Hanauer P, Slade J, Bero LA, Glantz SA. Environmental tobacco smoke. The Brown and Williamson documents. JAMA1995;:–53. | 12 | 38 |
| Wakefield M, Chaloupka F. Effectiveness of comprehensive tobacco control programmes in reducing teenage smoking in the USA. Tobacco Control 2000;9:177–86. | 12 | 48 |
| Glantz SA, Parmley WW. Passive smoking and heart disease. Mechanisms and risk. JAMA1995;:–53. | 11 | 157 |
| Fichtenberg CM, Glantz SA. Effect of smoke-free workplaces on smoking behaviour: systematic review. BMJ2002;:. | 11 | 62 |
| Borland R. A strategy for controlling the marketing of tobacco products: a regulated market model. Tobacco Control 2003;12:374–82. | 11 | 4 |
| Chapman S. Unravelling gossamer with boxing gloves: problems in explaining the decline in smoking. BMJ1993;:–32. | 9 | 32 |
| Fichtenberg CM, Glantz SA. Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease. N Engl J Med2000;:–7. | 9 | 63 |